Key result
Cardiac allograft ectopic lymphoid structures are linked to higher local IgG and ~19% donor-specific antibody detection.
Why the study?
Cardiac allograft vasculopathy involves ectopic lymphoid structures producing antibodies, but the antigenic targets of these locally produced antibodies were not characterized.
Observational (n=56)
Ectopic lymphoid structures in cardiac allografts contain active plasma cells that can locally produce donor-specific HLA antibodies, potentially contributing to graft rejection and cardiac allograft vasculopathy.
Answers are grounded in this paper and cite their sources.
May indicate ELS role in local DSA-mediated rejection; leaves open whether targeting these structures improves graft outcomes.
Cardiac allograft vasculopathy (CAV) is a transplant pathology, limiting graft survival after heart transplantation. CAV arteries are surrounded by ectopic lymphoid structures (ELS) containing B cells and plasma cells. The aim of this study was to characterize the antigenic targets of antibodies produced in ELS. Coronary arteries and surrounding epicardial tissue from 56 transplant recipients were collected during autopsy. Immunofluorescence was used to identify antibody-producing plasma cells. Immunoglobulin levels in tissue lysates were measured by enzyme-linked immunosorbent assay and analyzed for donor-specific HLA antibodies by Luminex assay. Cytokine and receptor expression levels were quantified using quantitative polymerase chain reaction. Plasma cells in ELS were polyclonal and produced IgG and/or IgM antibodies. In epicardial tissue, IgG (p < 0.05) and IgM levels were higher in transplant patients with larger ELS than smaller ELS. In 4 of 21 (19%) patients with ELS, donor-specific HLA type II antibodies were detected locally. Cytokine and receptor expression (CXCR3, interferon γ and TGF-β) was higher in large ELS in the epicardial tissue than in other vessel wall layers, suggesting active recruitment and proliferation of T and B lymphocytes. ELS exhibited active plasma cells producing locally manufactured antibodies that, in some cases, were directed against the donor HLA, potentially mediating rejection with major consequences for the graft.
No takes yet. Share an insight, caveat, or question.
Huibers et al. (2016) conducted an observational in Cardiac allograft vasculopathy (n=56). Ectopic lymphoid structures (ELS) vs. Smaller ELS or no ELS was evaluated on IgG and IgM levels and donor-specific HLA antibodies (p=< 0.05). Ectopic lymphoid structures in cardiac allografts were associated with higher local IgG levels, with donor-specific HLA type II antibodies detected locally in 19% of patients with ELS.
Synapse has enriched 10 related papers. Consider them for comparative context: